Lipid metabolism, human evolution and schizophrenia

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 60, Issue 5-6, 1999, Pages 431-437

  Horrobin, D F ^a  

^a Laxdale Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LIPID; PHOSPHOLIPID;

BRAIN NERVE CELL; BREAST; BUTTOCK; CONFERENCE PAPER; EVOLUTION; FATTY ACID TRANSPORT; GLIA CELL; HUMAN; HUMAN CELL; LIPID BRAIN LEVEL; LIPID METABOLISM; LIPID STORAGE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBCUTANEOUS FAT;

EID: 0032802983     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(99)80024-6     Document Type: Conference Paper

References (55)

1. 1. Horrobin D. F., Schizophrenia: the illness that made us human. Med Hypotheses 1998; 50: 269-288.
2. 2. Horrobin D. F. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 1998; 30: 193-208.
3. 3. Crawford M. A., Casperd N. M., Sinclair A. J. The long chain metabolites of linoleic and linolenic acids in liver and brain in herbivores and carnivores. Comp Biochem Physiol B 1976; 54: 395-401.
4. 4. Crawford M. A., Hassam A. G., Williams G. Essential fatty acids and fetal brain growth. Lancet 197G; 1: 452-453.
5. 5. Broadhurst S. L., Cunnane S. C., Crawford M. A. Rift valley lake fish and shellfish provided brain specific nutrition for early Homo. Br J Nutr 1997; 79: 3-21.
6. 6. Carlson S. E., Werkman S. H., Peeples J. M., Cooke R. J., Tolley E. A. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 1993; 90: 1073-1077.
7. 7. Koletzko B. Fats for brains. Eur J Clin Nutr 1992; 46: S51-S62.
8. 8. Hamosh M. Long-chain polyunsaturated fatty acids: who needs them? Biochem Soc Trans 1998; 26: 96-103.
9. 9. Makrides M., Neumann M., Simmer K., Pater J., Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 1995; 345: 1463-1468.
10. 10. Tavangar K., Murata Y., Patel S. et al. Developmental regulation of lipoprotein lipase in rats. Am J Physiol 1992; 262: E330-7.
11. 11. Shirai K., Saito Y., Yoshida S., Matsuoka N. Existence of lipoprotein lipase in rat brain microvessels. Tohoku J Exp Med 1986; 149: 449-450.
12. 12. Goldberg I. J. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996; 37: 693-707.
13. 13. Enerback S., Gimble J. M. Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level. Biochim Biophys Acta 1993; 1169: 107-125.
14. 14. Gavin L. A., Cavalieri R. R., Moeller M., McMahon F. A., Castle J. N., Gulli R. Brain lipoprotein lipase is responsive to nutritional and hormonal modulation. Metabolism 1987; 36: 919-924.
15. 15. Hang J., Rillema J. A. Prolactin's effects on lipoprotein lipase (LPL) activity and on LPL mRNA levels in cultured mouse mammary gland explants. Proc Soc Exp Biol Med 1997; 214: 161-166.
16. 16. Jemaa R., Tuzet S., Betoulle D., Apfelbaum M., Fumeron F. Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet. Int J Obes 1997; 21: 280-283.
17. 17. Bennett E., Stenvers K. L., Lund P. K., Popko B. Cloning and characterization of a cDNA encoding a novel fatty acid binding protein from rat brain. J Neurochem 1994; 63: 1616-1624.
18. 18. Myers-Payne SC, Hubell T, Pu L. et al. Isolation and characterization of two fatty acid binding proteins from mouse brain. J Neurochem 1996; 66: 1648-1656.
19. 19. Young J. K., Baker J. H., Muller T. Immunoreactivity for brain-fatty acid binding protein in gomori-positive astrocytes. Glia 1996; 16: 218-226.
20. 20. Owada Y., Yoshimoto T., Kondo H. Spatio-temporally differential expression of genes for three members of fatty acid binding proteins in developing and mature rat brains. J Chem Neuroanat 1996; 12: 113-122.
21. 21. Shimizu F., Watanabe T. K., Shinomiya H., Nakamura Y., Fujiwara T. Isolation and expression of a cDNA for human brain fatty acid-binding protein (B-FABP). Biochim Biophys Acta 1997; 1354: 24-28.
22. 22. Xu L. Z., Sanchez R., Sali A., Heintz N. Ligand specificity of brain lipid-binding protein. J Biol Chem 1996; 271: 24711-24719.
23. 23. Owada Y., Utsunomiya A., Yoshimoto T., Kondo H. Changes in gene expression for skin-type fatty acid binding protein in hypoglossal motor neurons following nerve crush. Neurosci Lett 1997; 223: 25-28.
24. 24. Owada Y., Yoshimoto T., Kondo H. Increased expression of the mRNA for brain- and skin-type but not heart-type fatty acid binding proteins following kainic acid systemic administration in the hippocampal glia of adult rats. Brain Res Mol Brain Res 1996; 42: 156-160.
25. 25. Liu Y., Molina C. A., Welcher A. A., Longo L. D., DeLeon M. Expression of DAII, a neuronal-injury-induced fatty acid binding protein, coincides with axon growth and neuronal differentiation during central nervous system development. J Neurosci Res 1997; 48: 551-562.
26. 26. Godbout R., Bisgrove D. A., Shkolny D., Day RS 3rd. Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene 1998; 16: 1955-1962.
27. 27. Utsunomiya A., Owada Y., Yoshimoto T., Kondo H. Localization of mRNA for fatty acid transport protein in developing and mature brain of rats. Brain Res Mol Brain Res 1997; 46: 217-222.
28. 28. Feng L., Heintz N. Differentiating neurons activate transcription of the brain lipid-binding protein gene in radial glia through a novel regulatory element. Development 1995; 121: 1719-1730.
29. 29. Alvarez Buylla A. Neurogenesis and plasticity in the CNS of adult birds. Exp Neurol 1992; 115: 110-114.
30. 30. Rousselot P., Heintz N., Nottebohm F. Expression of brain lipid binding protein in the brain of the adult canary and its implications for adult neurogenesis. J Comp Neurol 1997; 385: 415-426.
31. 31. Wobus A. M., Zschiesche W., Grosse R. Differentiation-promoting effects of mammary-derived growth inhibitor (MDGI) on pluripotent mouse embryonic stem cells. Virchows Archiv Cell Pathol 1990; 59: 339-342.
32. 32. Kurtz A., Vogel F., Funa K., Heldin C. H., Grosse R. Developmental regulation of mammary-derived growth inhibitor expression in bovine mammary tissue. J Cell Biol 1990; 110: 1779-1789.
33. 33. Bohmer F. D., Kraft R., Otto A. et al. Identification of a polypeptide growth inhibitor from bovine mammary gland. Sequence homology to fatty acid- and retinoid-binding proteins. J Biol Chem 1987; 262: 15137-15143.
34. 34. Motojima K., Passilly P., Peters J. M., Gonzalez F. J., Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 1998; 273: 16710-16714.
35. 35. MacDonald J. I., Sprecher H. Phospholipid fatty acid remodeling in mammalian cells. Biochim Biophys Acta 1991; 1084: 105-121.
36. 36. Snyder F., Lee T. C., Blank M. L. The role of transacylases in the metabolism of arachidonate and platelet activating factor. Prog Lipid Res 1992; 31: 65-86.
37. 37. Cao Y., Traer E., Zimmerman G. A., McIntyre T. M., Prescott S. M. Cloning, expression, and chromosomal localization of human long-chain fatty acid CoA ligase 4 (FACL4). Genomics 1998; 49: 327-330.
38. 38. Deka N., Sun G. Y., MacQuarrie R. Purification and properties of acyl-CoA:1-acyl-sn-glycero-3-phosphocholine-O-acyltransferase from bovine brain microsomes. Arch Biochem Biophys 1986; 246: 554-563.
39. 39. Eberhardt C., Gray P. W., Tjoelker L. W. Human lysophosphatidic acid acyltransferase. cDNA cloning, expression, and localization to chromosome 9q34.3. J Biol Chem 1997; 272: 20299-20305.
40. 40. West J., Tompkins C. K., Balantac N. et al. Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells. DNA Cell Biol 1997; 16: 691-701.
41. 41. Ojima A., Nakagawa Y., Sugiura T., Masuzawa Y., Waku K. Selective transacylation of 1-O-alkylglycerophosphoethanolamine by docosahexaenoate and arachidonate in rat brain microsomes. J Neurochem 1987; 48: 1403-1410.
42. 42. Masuzawa Y., Sugiura T., Sprecher H., Waku K. Selective acyl transfer in the reacylation of brain glycerophospholipids. Comparison of three acylation systems for 1-alk 1′-enylglycero-3-phosphoethanolamine, 1-acylglycero-3-phosphoethanolamine and 1-acylglycero-3-phosphocholine in rat brain microsomes. Biochim Biophys Acta 1989; 1005: 1-12.
43. 43. Natarajan V., Schmid P. C., Reddy P. V., Zuzarte Augustin M. L., Schmid H. H. Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations. J Neurochem 1983; 41: 1303-1312.
44. 44. Jolly C. A., Murphy E. J., Schroeder F. Differential influence of rat liver fatty acid binding protein isoforms on phospholipid fatty acid composition: phosphatidic acid biosynthesis and phospholipid fatty acid remodeling. Biochim Biophys Acta 1998; 1390: 258-268.
45. 45. Davidovitch M., Patterson B., Gartside P. Head circumference measurements in children with autism. J Child Neurol 1996; 11: 389-393.
46. 46. Negre-Aminou P., Nemenoff R. A, Wood M. R., de la Houssaye B. A., Pfenninger K. H. Characterization of phospholipase A2 activity enriched in the nerve growth cone. J Neurochem 1996; 67: 2599-2608.
47. 47. Yamagata K., Andreasson K. I., Kaufmann W. E., Barnes C. A., Worley P. F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993; 11: 371-386.
48. 48. Kaufmann W. E., Worley P. F., Pegg J., Bremer M., Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 1996; 93: 2317-2321.
49. 49. Smalheiser N. R., Dissanayake S., Kapil A. Rapid regulation of neuritc outgrowth and retraction by phospholipase A2-derived arachidonic acid and its metabolites. Brain Res 1996; 721: 39-48.
50. 50. Horrobin D. F. Schizophrenia as a prostaglandin deficiency disease. Lancet 1977; 1: 936-937.
51. 51. Horrobin D. F. The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism. Prostaglandins Leukotr EFAs 1992; 46: 71-77.
52. 52. Horrobin D. F., Glen A. I., Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr Res 1994; 13: 195-207.
53. 53. Heston L. L. The genetics of schizophrenic and schizoid diseases. Science 1970; 167: 249-256.
54. 54. Karlsson J. L. Inheritance of schizophrenia. Acta Psychiatr Scand Suppl 1974; 274: 1-116
55. 55. Crow T. J. A Darwinian approach to the origins of psychosis. Br J Psychiatry 1995; 167: 12-25.